Tolfenamic acid and leukotriene synthesis inhibition.
Moilanen
E
E
Department of Clinical Pharmacology, Tampere University Hospital, Finland.
Kankaanranta
H
H
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D015550:Cell Degranulation / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D006801:Humans; D007975:Leukotriene B4 / Q000037:antagonists & inhibitors*; D009504:Neutrophils / Q000187:drug effects; D010972:Platelet Activating Factor / Q000187:drug effects; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010972:Platelet Activating Factor; D062367:ortho-Aminobenzoates; D007975:Leukotriene B4; C009500:tolfenamic acid